Ocugen CSO to Participate in 5th Annual Gene Therapy for Ophthalmic Disorders Summit

Thursday, September 5, 2024 1 min read

Key Takeaway: Ocugen CSO to Participate in 5th Annual Gene Therapy for Ophthalmic Disorders Summit

Full Press Release Details

Ocugen CSO to Participate in 5th Annual Gene Therapy for Ophthalmic Disorders Summit.